DVN three-lens brief
Evidence-based stock research on DVN. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Analyst mean target $59.28 — 17% above current (25 analysts). · Trading at 92% of its 52-week range — near the top of the band.
- Trading at 92% of its 52-week range — near the top of the band.
- Analyst mean target $59.28 — 17% above current (25 analysts).
- Debt-to-equity of 56.0 — balance-sheet-heavy.
DVN closed at $50.84 (+0.55%) as of 2026-05-04. Market cap: $31.59B. P/E (trailing) 12.2. Positives: analyst mean target $59.28 — 17% above current (25 analysts).. Concerns: trading at 92% of its 52-week range — near the top of the band.; debt-to-equity of 56.0 — balance-sheet-heavy.. Last quarter: Revenue $4.12B, net income $562.00M, free cash flow $2.12B.
Why three lenses on DVN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine DVNacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/DVN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath DVN brief"></iframe>